Abstract
The hypoxia-inducible factor HIF-1 has been shown to be mandatory for the cellular adaptation to hypoxia. In addition, evidence has been provided that HIF-1 can mediate various stress responses and that it may play an important role under inflammatory conditions even independently of hypoxia. HIF-1 is a heterodimer consisting of an α-subunit which is subject to tight regulation, and a β-subunit, also termed ARNT, which appears to be constitutively expressed. In addition to the complex network controlling the cellular content of HIF-1α at the level of protein stability, recent evidence showed that HIF-1α levels can also be regulated at the mRNA level. In fact, transcriptional regulatory networks seem to be an additional way of controlling HIF-1α levels and may open new therapeutic options to modulate HIF-1α also under non-hypoxic conditions.
Original language | English |
---|---|
Pages (from-to) | 3844-3852 |
Number of pages | 9 |
Journal | Current Pharmaceutical Design |
Volume | 15 |
Issue number | 33 |
DOIs | |
State | Published - Nov 2009 |
Keywords
- HIF
- Hypoxia
- Nuclear factor kappa b
- Promoter
- Reactive oxygen species
- Transcription